ALB and pulmonary edema: However, including additional participants in phase III showed that intravenous administration of a 25% human serum albumin solution at 2.0 g/kg was not associated with the 90-day clinical outcome but was associated with an increased incidence of cerebral hemorrhage and pulmonary edema (36).